Medical Director, Out-Patient Dialysis Unit, Indiana University Hospital; Professor of Clinical Medicine, Indiana University School of Medicine
Nephrology
Dr. Jay B. Wish, MD
|
|
Give Review
Dr. Jay B. Wish works in the field of Nephrology. He studied medicine at Tufts University School of Medicine. Tufts University School of Medicine has a rank of 49 in research and a 52 in primary care He received awards:"Regional Top Doctor", "Whos Who in America", "Best Doctors in America", "Master Clinician Educator", "Inpatient Teacher of the Year", "Visionary Award", "Case Western Reserve University chapter annual dinner speaker", "Jeopardy champion", "Top MD" and "Whos Who in Medicine and Healthcare". Wish is also a published doctor. He has 71 publication published. The most recent publication is: The cost of implementing the Dialysis Outcomes Quality Initiative Clinical Practice Guidelines. He accepts Medicare payments and is registered with Medicare.gov.
Publications
- New Options for Iron Supplementation in Maintenance Hemodialysis Patients.
- Rebasing the Medicare Payment for Dialysis: Rationale, Challenges, and Opportunities.
- Medical Director Responsibilities to the ESRD Network.
- The Approval Process for Biosimilar Erythropoiesis-Stimulating Agents.
- The KDIGO anemia guideline: can reason triumph over regulation?
- Are consistency and individualization mutually exclusive in erythropoiesis-stimulating agent therapy?
- Erythropoiesis-stimulating agents and pure red-cell aplasia: you can't fool Mother Nature.
- Hemoglobin variability as a predictor of mortality: What's a practitioner to do?
- Anemia management under a bundled payment policy for dialysis: a preview for the United States from Japan.
- Vascular access for dialysis in the United States: progress, hurdles, controversies, and the future.
- Fistula First: myth vs. fact.
- Dialysis delivery in Canada and the United States: a view from the trenches.
- Posttransplant anemia: the role of sirolimus.
- Past, present, and future of chronic Kidney disease anemia management in the United States.
- New ESRD clinical performance measures and data collection system: progress and pitfalls.
- Use of erythropoiesis-stimulating agents in patients with anemia of chronic Kidney disease: overcoming the pharmacological and pharmacoeconomic limitations of existing...
- Assessing Iron status: beyond serum ferritin and transferrin saturation.
- Should patients get EPO subcutaneously?
- Management of anemia in patients with chronic Kidney disease.
- Can evidence drive the development of a sound national EPO reimbursement policy?
- Improving the care of ESRD patients: a success story.
- The biological and economic value of oral organic Iron in maintenance dialysis.
- Potential cost savings of erythropoietin administration in end-stage renal Disease.
- Recovery of Renal Function among ESRD Patients in the US Medicare Program.
- What is expected of a medical director in the Centers for Medicare and Medicaid Services Conditions of Coverage?
- The ESA saga: a perfect storm of failed expectations and over-regulation.
- Taking a subq approach to EPO: experience in the clinic.
- The morbidity and cost implications of hemodialysis clinical performance measures.
- Anemia in renal Disease: diagnosis and management.
- Intravenous Iron: not just for hemodialysis patients anymore.
- Postdialysis outcomes associated with consistent anemia treatment in predialysis patients with chronic Kidney disease.
- Subcutaneous erythropoietin results in lower dose and equivalent hematocrit levels among adult hemodialysis patients: Results from the 1998 End-Stage Renal Disease Cor...
- Introduction: Continuous quality improvement in dialysis units.
- Quality and accountability in the ESRD program.
- Management of anemia in chronic Kidney disease (predialysis) patients: nephrology nursing implications.
- Medspeak.
- Repair of transplant Renal artery stenosis by hypogastric to Renal artery fistula.
- Immunologic effects of cyclosporine.
- Insulin resistance in chronic renal Failure.
- Defective phagocytosis due to tuftsin deficiency in splenectomized subjects.
- Aldosterone and the Renal response to sulfuric acid feeding in the dog.
- Disorders of acid-base Metabolism.
- Hospital-acquired Renal insufficiency: a prospective study.
- Failure of increased sodium avidity to facilitate renal acid excretion in dogs fed sulfuric acid.
- Quality in dialysis: an interdisciplinary challenge.
- Implementing the Health Care Quality Improvement Program in the Medicare ESRD Program: a new era of quality improvement in ESRD.
- The Ad Hoc Committee report on estimating the future workforce and training requirements for nephrology. The Ad Hoc Committee on Nephrology Manpower Needs.
- Comparative cost analysis of PD modalities in the "adequacy" era.
- How will we manage ESRD patients in the future?
- Introduction to quality improvement.
- Data management to understand outcomes and trends in ESRD.
- Role of external oversight in quality activities: accreditation, credentialing, licensure, and deemed status.
- The impact of workforce issues, accountability for patient outcomes. The specialist's role in the 21st century. Part I.
- Scope of practice, the pre-ESRD patient, the principal physician, physician extenders. The specialist's role in the 21st century.
- Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project.
- The forum of ESRD networks: past, present and future.
- Regional variability in anaemia management and haemoglobin in the US.
- Improving outcomes in CKD and ESRD patients: carrying the torch from training to practice.
- Physician workforce: coming up short.
- Healthcare expenditure and resource utilization in patients with anaemia and chronic Kidney disease: a retrospective claims database analysis.
- Hydralazine-induced ANCA-positive pauci-immune Glomerulonephritis: a case report and literature review.
- The patient-centered medical home: managed care repackaged or something better?
- The 2009 proposed rule for prospective ESRD payment: perspectives from the forum of ESRD networks.
- Burden of illness for patients with non-dialysis chronic Kidney disease and anemia in the United States: review of the literature.
- The cost of implementing the Dialysis Outcomes Quality Initiative Clinical Practice Guidelines.
- The safety of intravenous Iron dextran in hemodialysis patients.
- Has recombinant human erythropoietin therapy minimized red-cell transfusions in hemodialysis patients?
- Performance measures, accountability, and public policy.
- Goal setting & Network 9/10 efforts to improve care.
- NephTrak and the Renal Network Data System (TRNDS).
Schools
Tufts University School Of Medicine
New Eng Med Center Hospital
Procedures Preformed
- Arteriovenostomy for Renal Dialysis
- End-Stage Renal Disease Related Services
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Glomerulonephritis
- Acute Kidney Failure
- Alkalosis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Regional Top Doctor
- Who’s Who in America
- Best Doctors in America
- Master Clinician Educator
- Inpatient Teacher of the Year
- Visionary Award
- Case Western Reserve University chapter annual dinner speaker
- Jeopardy champion
- Top MD
- Whos Who in Medicine and Healthcare
Education
-
Tufts Medical Center -
Tufts University School of Medicine
Drug Facts
| NPI NUMBER | 1851311922 | |
| NPPES Provider LastName | WISH | |
| NPPES Provider FirstName | JAY | |
| NPPES Provider ZIPCode | 462021228 | |
| NPPES Provider State | IN | |
| Specialty Description | Nephrology | |
| Total Claim Count | 1755.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 86.0 | |
| Percent Opioid Claims | 4.9 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1851311922 |
| Last Name Of The Provider | WISH |
| First Name Of The Provider | JAY |
| View All |
Similar Doctors
|
Dr. Charles B. Carter Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Theodore Hegeman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Landon E. Dickson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael T. Eadon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephanie A. Riggen, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jay H. Weiss, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ranjani N. Moorthi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dennis P. Mishler, MD
This Doctor is OpenDoctor Recommended.
|